Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. Financials
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization1 6 83716 07197 797--
Entreprise Value (EV)2 6 31814 96489 21581 94277 738
P/E ratio -35,6x1 112x13,4x14,5x28,7x
Yield -----
Capitalization / Revenue 63,0x33,3x7,48x8,45x11,7x
EV / Revenue 58,2x31,0x6,83x7,08x9,30x
EV / EBITDA -42,8x-343x7,65x7,92x12,7x
Price to Book 13,9x11,8x15,1x8,21x7,24x
Nbr of stocks (in thousands) 226 262240 786241 521--
Reference price (EUR) 30,266,7405405405
Announcement Date 03/31/202003/30/2021---
1 USD in Million
2 EUR in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023
Net sales1 10948213 07111 5728 363
EBITDA1 -148-43,711 65810 3506 129
Operating profit (EBIT)1 -182-82,410 5419 4295 532
Operating Margin -167%-17,1%80,6%81,5%66,1%
Pre-Tax Profit (EBT)1 -179-14611 33311 2825 891
Net income1 -17915,27 5907 1113 698
Net margin -165%3,15%58,1%61,5%44,2%
EPS2 -0,850,0630,328,014,1
Dividend per Share2 -----
Announcement Date 03/31/202003/30/2021---
1 EUR in Million
2 EUR
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4
Net sales1 67,53452 0483 2743 2593 425
EBITDA1 -1782571 6752 5282 3132 572
Operating profit (EBIT)1 -1862441 6622 5542 4402 440
Operating Margin -276%70,7%81,1%78,0%74,9%71,2%
Pre-Tax Profit (EBT)1 -2082061 6422 6372 6422 548
Net income1 -2103671 1281 7841 8281 911
Net margin -311%106%55,1%54,5%56,1%55,8%
EPS2 -0,881,574,396,947,237,53
Dividend per Share ------
Announcement Date 11/10/202003/30/202105/10/2021---
1 EUR in Million
2 EUR
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt1 -----
Net Cash position1 5191 1078 58115 85520 059
Leverage (Debt / EBITDA) 3,52x25,4x-0,74x-1,53x-3,27x
Free Cash Flow1 -237-79,58 1257 9374 384
ROE (Net Profit / Equities) -47,1%1,63%133%47,1%3,16%
Shareholders' equity1 3809335 70515 102117 109
ROA (Net Profit / Asset) -24,7%0,98%113%39,7%2,86%
Assets1 7251 5586 69417 893129 493
Book Value Per Share2 2,185,6826,949,355,9
Cash Flow per Share2 -0,94-0,0528,717,01,88
Capex1 38,666,0209103123
Capex / Sales 35,5%13,7%1,60%0,89%1,46%
Announcement Date 03/31/202003/30/2021---
1 EUR in Million
2 EUR
Key data
Capitalization (USD) 97 796 709 639
Net sales (EUR) 482 325 000
Net sales (USD) 570 735 173
Number of employees 2 200
Sales / Employee (EUR) 219 239
Sales / Employee (USD) 259 425
Free-Float 87,3%
Free-Float capitalization (USD) 85 344 969 529
Avg. Exchange 20 sessions (EUR) 1 994 887 072
Avg. Exchange 20 sessions (USD) 2 360 549 872
Average Daily Capital Traded 2,04%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA